Earnings Preview For Viking Therapeutics

Viking Therapeutics VKTX is set to give its latest quarterly earnings report on Wednesday, 2025-04-23. Here's what investors need to know before the announcement.

Analysts estimate that Viking Therapeutics will report an earnings per share (EPS) of $-0.32.

Investors in Viking Therapeutics are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

Performance in Previous Earnings

During the last quarter, the company reported an EPS missed by $0.05, leading to a 6.09% drop in the share price on the subsequent day.

Here's a look at Viking Therapeutics's past performance and the resulting price change:

Viking Therapeutics Share Price Analysis

Shares of Viking Therapeutics were trading at $23.72 as of April 21. Over the last 52-week period, shares are down 61.43%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

To track all earnings releases for Viking Therapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.